未登录

A

Andrea Casazza

KU Leuven

H指数:16

被引数:2,825

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Recombinant human placental growth factor-2 in post-infarction left ventricular dysfunction: a randomized, placebo-controlled, preclinical study

BASIC RESEARCH IN CARDIOLOGY

IF8

2024-08-010

PRE

Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue Sarcoma

IF3.9

2022-04-061

OAAI

PhAc-ALGP-Dox, a Novel Anticancer Prodrug with Targeted Activation and Improved Therapeutic Index

MOLECULAR CANCER THERAPEUTICS

IF5.5

2022-02-115

OAAI

Non-thermal Plasma as an Innovative Option for the Abatement of Volatile Organic Compounds: a Review

WATER AIR AND SOIL POLLUTION

IF3

2017-09-2179

PREAI

In Vivo Antitumoral Efficacy of PhAc-ALGP-Doxorubicin, an Enzyme-Activated Doxorubicin Prodrug, in Patient-Derived Soft Tissue Sarcoma Xenograft Models

MOLECULAR CANCER THERAPEUTICS

IF5.5

2017-08-0216

OAAI

PhAc-ALGP-Dox is a new tumor selective peptide prodrug of doxorubicin that shows improved efficacy and systemic tolerance in triple negative breast cancer models

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity

NATURE COMMUNICATIONS

IF15.7

2017-02-1575

OAAI

Hernandez-Fernaud, Juan R.; Ruengeler, Elena; Casazza, Andrea; Neilson, Lisa J.; Pulleine, Ellie; Santi, Alice; Ismail, Shehab; Lilla, Sergio; Dhayade, Sandeep; MacPherson, Iain R.; McNeish, Iain; Ennis, Darren; Ali, Hala; Kugeratski, Fernanda G.; Al Khamici, Heba; van den Biggelaar, Maartje; van den Berghe, Peter V. E.; Cloix, Catherine; McDonald, Laura; Millan, David; Hoyle, Aoisha; Kuchnio, Anna; Carmeliet, Peter; Valenzuela, Stella M.; Blyth, Karen; Yin, Huabing; Mazzone, Massimiliano; Norman, Jim C.; Zanivan, Sara

Identification of a chronic non-neurodegenerative microglia activation state in a mouse model of peroxisomal -oxidation deficiency

IF5.1

2015-04-0233

OAAI

Altering the intratumoral localization of macrophages to inhibit cancer progression

IF6.3

2014-02-1410

OAAI

Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice (vol 120, pg 2684, 2010)

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2013-12-020

OA

Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment

肿瘤基质: 缺氧肿瘤微环境决定的复杂性

IF7.3

2013-04-22222

OA

Challenges with Developing In Vitro Dissolution Tests for Orally Inhaled Products (OIPs)

AAPS PHARMSCITECH

IF4

2012-07-1492

OA

miR-511-3p Modulates Genetic Programs of Tumor-Associated Macrophages

IF6.9

2012-02-01190

OA

Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform

EMBO MOLECULAR MEDICINE

IF8.3

2012-01-1388

OAAI

Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice (vol 120, pg 2684, 2010)

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2011-07-010

OA

Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2011-04-01105

OAAI

Targeting Semaphorin signaling to inhibit tumor growth and metastatic spreading

CANCER RESEARCH

IF16.6

2011-04-010

PRE

NMR spectroscopy and surface tension measurements applied to the study of self-association of casopitant mesylate, a novel NK1 antagonist

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2011-01-012

PREAI

Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2010-08-02156

OA

The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment

JOURNAL OF EXPERIMENTAL MEDICINE

IF10.6

2008-05-0589

OAAI